Amit Mahajan, MD, FCCP, DAABIP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Ambu USA
    Topic:
    Educational Consultant
    Date added:
    02/08/2024
    Date updated:
    09/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    AstraZeneca
    Topic:
    Educational Consultant
    Date added:
    02/16/2024
    Date updated:
    09/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Circulogene
    Topic:
    Educational Consultant
    Date added:
    02/16/2024
    Date updated:
    09/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Noah Medical
    Topic:
    Educational Consultant
    Date added:
    02/16/2024
    Date updated:
    09/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Olympus Corporation
    Topic:
    Educational Consultant
    Date added:
    02/16/2024
    Date updated:
    09/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Pulmonx Corporation
    Topic:
    Educational Consultant
    Date added:
    02/16/2024
    Date updated:
    09/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Philips Corporation
    Topic:
    Educational Consultant
    Date added:
    02/16/2024
    Date updated:
    09/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Concur Biophotonics
    Topic:
    Educational Consultant
    Date added:
    09/25/2025
    Date updated:
    09/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Eon
    Topic:
    Educational Consultant
    Date added:
    09/25/2025
    Date updated:
    09/25/2025
Return to 2026 Inova Fairfax Medicine Grand Rounds: Bronchoscopic Lung Volume Reduction (BLVR) -- A Step Forward for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)